Results 31 to 40 of about 355,907 (356)

A real-world experience of transition to robotic-assisted thoracic surgery (RATS) for lung resections

open access: yesFrontiers in Surgery, 2023
ObjectiveWe report our experience of transition to robotic-assisted thoracic surgery (RATS) for lung resections with the da Vinci Xi surgical system, exposing short-term results.Materials and methodsThis is a single-center, retrospective analysis of RATS
Alessandro Palleschi   +4 more
doaj   +1 more source

Perioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients [PDF]

open access: yes, 1995
Background.: We and others have demonstrated that a low level of donor cell chimerism was present for years after transplantation in tissues and peripheral blood of heart and lung recipients; it was associated, in the latter, with a lower incidence of ...
Abdul S. Rao   +34 more
core   +1 more source

The Relationship Between Bacterial Pathogen Presence Detected by Bronchial Lavage and Acute Rejection: 1-Year Follow-up Results Following Lung Transplantation

open access: yesHaseki Tıp Bülteni, 2022
Aim:Lung transplant recipients are the highest risk group in terms of infective complications among solid organ transplants. It has improved the management of the most common infectious complications with the aid of advances in diagnostic methods ...
Pinar Atagun Guney   +7 more
doaj   +1 more source

Autologous pericardium used for reconstruction of left innominate vein in patient with mediastinal venous aneurysm:a case report

open access: yesBMC Surgery, 2020
Background Mediastinal venous aneurysm is a very rare disease and can be easily misdiagnosed. Patients are often asymptomatic while venous aneurysm of large size with adjacent structures oppressed can lead to discomfort.
Cheng Fang   +4 more
doaj   +1 more source

Tüdőtranszplantáció magyar betegek számára [PDF]

open access: yes, 2013
When conservative treatment fails, lung transplantation often remains the only therapeutic option for patients with end stage parenchymal or vascular lung diseases.
Czebe K   +3 more
core   +1 more source

Biomarkers in solid organ transplantation: establishing personalized transplantation medicine. [PDF]

open access: yes, 2011
Technological advances in molecular and in silico research have enabled significant progress towards personalized transplantation medicine. It is now possible to conduct comprehensive biomarker development studies of transplant organ pathologies ...
Khatri, Purvesh   +3 more
core   +3 more sources

High-affinity CD16 integration into a CRISPR/Cas9-edited CD38 locus augments CD38-directed antitumor activity of primary human natural killer cells

open access: yesJournal for ImmunoTherapy of Cancer, 2022
Background Adoptive transfer of natural killer (NK) cells with augmented antibody-dependent cellular cytotoxicity (ADCC) capabilities and resistance to CD38 targeting has the potential to enhance the clinical anti-myeloma activity of daratumumab (DARA ...
Long Chen   +8 more
doaj   +1 more source

Advances in Lung Transplantation

open access: yesCells, 2023
Nowadays, lung transplantation is a clinical reality for the treatment of benign end-stage respiratory diseases [...]
Davide Tosi, Alessandro Palleschi
openaire   +3 more sources

Annual Report of the Indian Society for Heart and Lung Transplantation Registry 2024 (INTRAN)

open access: yesJournal of the Practice of Cardiovascular Sciences
This is a registry report of the Indian Society for Heart and Lung Transplantation. The data reflects thoracic transplants done in India since 1994. It is a voluntary cloud-based registry.
Indian Society for Heart and Lung Transplantation (INSHLT)
doaj   +1 more source

Rattus Model Utilizing Selective Pulmonary Ischemia Induces Bronchiolitis Obliterans Organizing Pneumonia [PDF]

open access: yes, 2013
Bronchiolitis obliterans organizing pneumonia (BOOP), a morbid condition when associated with lung transplant and chronic lung disease, is believed to be a complication of ischemia.
Clough, Anne V.   +7 more
core   +2 more sources

Home - About - Disclaimer - Privacy